References and Notes
1
Staudinger M.
Justus Liebigs Ann. Chem.
1907,
356:
51
2
Taggi AE.
Hafez AM.
Wack H.
Young B.
Ferraris D.
Lectka T.
J. Am. Chem. Soc.
2002,
124:
6626
3
Neuhaus FC.
Georgopapadakou NH.
Emerging Targets in Antibacterial and Antifungal Chemotherapy
Sutcliffe JA.
Georgopapadakou NH.
Chapman and Hall;
New York:
1992.
4
Lee EC.
Hodous BL.
Bergin E.
Shih C.
Fu GC.
J. Am. Chem. Soc.
2005,
127:
11586
5
Hodous BL.
Fu GC.
J. Am. Chem. Soc.
2002,
124:
1578
6
Taggi AE.
Hafez AM.
Wack H.
Young B.
Drury WJ.
Lectka T.
J. Am. Chem. Soc.
2000,
122:
7831
7
Magriotis PA.
Angew. Chem. Int. Ed.
2001,
40:
4377
8
France S.
Guerin DJ.
Miller SJ.
Lectka T.
Chem. Rev.
2003,
103:
2985
9
France S.
Weatherwax A.
Taggi AE.
Lectka T.
Acc. Chem. Res.
2004,
37:
592
10
Palomo C.
Aizpurua JM.
Ganboa I.
Oiarbide M.
Eur. J. Inorg. Chem.
1999,
3223
11
Jiao L.
Zhang Q.
Liang Y.
Zhang S.
Xu J.
J. Org. Chem.
2006,
71:
815
12
Moore HW.
Hernandez L.
Chambers R.
J. Am. Chem. Soc.
1978,
100:
2245
13
Jiao L.
Liang Y.
Xu J.
J. Am. Chem. Soc.
2006,
128:
6060
14
Moore HW.
Hughes G.
Srinivasachar K.
Fernandez M.
Nguyen NV.
Schoon D.
Tranne A.
J. Org. Chem.
1985,
50:
4231
15
Alonso E.
López-Ortiz F.
del Pozo C.
Peralta E.
Macías A.
González J.
J. Org. Chem.
2001,
66:
6333
16
Georg GI.
Ravikumar VT. In The Organic Chemistry of β-Lactams
Georg GT.
Verlag Chemie;
New York:
1993.
p.295
17
Palomo C.
Aizpurua JM.
Ganboa I.
Oiarbide M.
Curr. Med. Chem.
2004,
11:
1837
18
Chemistry and Biology of β-Lactams Antibiotics
Vol. 1-3:
Morin RB.
Goldman M.
Academic;
New York:
1982.
19
Antibiotics Containing the β-Lactam Structure
Parts 1 and 2:
Demain AL.
Solomon NA.
Springer;
Berlin:
1983.
20
Recent Advances in the Chemistry of Antiinfective Agents
Bentley PH.
Ponsford R.
Royal Society of Chemistry;
Cambridge:
1993.
21
Bronson JJ.
Barrett JF.
Curr. Med. Chem.
2001,
8:
1775
22
Fülöp F.
Chem. Rev.
2001,
101:
2181
23
Fülöp F.
Martinek TA.
Tóth GK.
Chem. Soc. Rev.
2006,
35:
323
24
Braun M.
Sacha H.
Galle D.
El-Alali A.
Tetrahedron Lett.
1995,
36:
4213
25
Hussein MA.
Iida A.
Tomioka K.
Tetrahedron
1999,
55:
11219
26
General Experimental Procedure
An imine30,31 (0.1 mmol) and a ketene4,5,32 (0.25 mmol) were dissolved in dry THF (1 mL) and cooled down to -78 °C. Then, KHMDS (0.01 mmol) was added, and the reaction was monitored by TLC. After total conversion the reaction mixture was applied to column chromatography on silica gel and products were eluted with 1:8 EtOAc-PE mixture to give the desired compounds as white solids (yields: 48-99%).
Compound 5a (trans-isomer): white crystals, mp 144 °C. 1H NMR (200 MHz, CDCl3): δ = 0.57 (t, J = 7.4 Hz, 3 H), 1.25-1.43 (m, 1 H), 1.64-1.89 (m, 1 H), 5.24 (s, 1 H), 7.21-7.44 (m, 10 H), 8.12 (d, J = 8.9 Hz, 2 H), 8.34 (d, J = 8.98 Hz, 2 H). 13C NMR (50 MHz, CDCl3): δ = 8.65, 27.14, 68.07, 69.92, 124.57, 126.23, 127.21, 128.13, 128.92, 129.19, 129.26, 133.59, 137.42, 143.94, 151.03, 168.60. IR (KBr): ν = 1792 (C=O) cm-1. MS (ES+): m/z = 459.1 [M + Na]+, 895.0 [2 M + Na]+. Anal. Calcd (%) for C23H20N2O5S: C, 63.29; H, 4.62; N, 6.42. Found: C, 63.20; H, 4.67; N, 6.35.
Compound 5a (cis-isomer): white crystals, mp 144-145 °C. 1H NMR (200 MHz, CDCl3): δ = 0.94 (t, J = 7.4 Hz, 3 H), 2.20 (q, J = 7.4 Hz, 2 H), 5.15 (s, 1 H), 6.70-6.76 (m, 2 H), 6.82-6.91 (m, 2 H), 6.94-7.16 (m, 6 H), 7.95 (d, J = 8.9 Hz, 2 H), 8.26 (d, J = 8.9 Hz, 2 H). 13C NMR (50 MHz, CDCl3): δ = 9.31, 32.61, 69.14, 70.26, 124.40, 127.24, 127.41, 128.16, 128.19, 128.28, 128.88, 129.01, 133.66, 134.47, 144.36, 150.84, 167.80. IR (KBr): ν = 1792 (C=O) cm-1. MS (ES+): m/z = 459.1 [M + Na]+, 895.0 [2 M + Na]+. Anal. Calcd (%) for C23H20N2O5S: C, 63.29; H, 4.62; N, 6.42. Found: C, 63.38; H, 4.73; N, 6.28.
Compound 5b: Analytical data were consistent with those for 5a.
Compound 5c (trans-isomer): white crystals, mp 107 °C. 1H NMR (400 MHz, CDCl3): δ = 0.83 (t, J = 8.0 Hz, 3 H), 2.09-2.17 (m, 1 H), 2.24-2.33 (m, 1 H), 5.64 (s, 1 H), 6.70-6.72 (m, 1 H), 6.81-6.84 (m, 1 H), 6.95-6.98 (m, 2 H), 7.03-7.07 (m, 3 H), 7.29-7.23 (m, 2 H), 8.22 (d, J = 8.8 Hz, 2 H), 8.43 (d, J = 8.8 Hz, 2 H). 13C NMR (100 MHz, CDCl3): δ = 9.31, 30.74, 64.74, 71.53, 124.78, 126.89, 128.51, 129.32, 129.41, 129.66, 132.29, 133.12, 134.10, 143.82, 151.19, 168.44. IR (KBr): ν = 1787 (C=O) cm-1. MS (ES+): m/z = 493.1 [M + Na]+. Anal. Calcd (%) for C23H19ClN2O5S: C, 58.66; H, 4.07; N, 5.95. Found: C, 58.45; H, 4.05; N, 5.97.
Compound 5c (cis-isomer): white crystals, mp 107 °C. 1H NMR (200 MHz, CDCl3): δ = 0.59 (t, J = 7.4 Hz, 3 H), 1.70 (q, J = 7.3 Hz, 2 H), 5.56 (s, 1 H), 7.03-7.07 (m, 5 H), 7.34-7.48 (m, 4 H), 8.15 (d, J = 8.8 Hz, 2 H), 8.37 (d, J = 8.8 Hz, 2 H). 13C NMR (50 MHz, CDCl3): δ = 8.62, 25.4, 64.69, 69.50, 124.68, 126.65, 127.84, 128.29, 129.96, 129.22, 132.16, 133.08, 133.96, 143.60, 151.14, 168.13. IR (KBr): ν = 1793 (C=O) cm-1. MS (ES+): m/z = 493.1 [M + Na]+. Anal. Calcd (%) for C23H19ClN2O5S: C, 58.66; H, 4.07; N, 5.95. Found: C, 58.71; H, 4.09; N, 5.81.
Compound 5d (trans-isomer): white crystals, mp 142 °C. 1H NMR (200 MHz, CDCl3): δ = 0.57 (t, J = 7.4 Hz, 3 H), 1.25-1.43 (m, 1 H), 1.59-1.83 (m, 1 H), 2.39 (s, 3 H), 5.21 (s, 1 H), 7.21-7.43 (m, 9 H), 8.12 (d, J = 9.0 Hz, 2 H), 8.35 (d, J = 9.04 Hz, 2 H). 13C NMR (50 MHz, CDCl3): δ = 8.67, 21.36, 27.17, 67.96, 69.90, 124.55, 126.24, 127.16, 128.06, 129.16, 130.50, 137.51, 139.24, 143.99, 151.06, 168.71. IR (KBr): ν = 1785 (C=O) cm-1. MS (ES+): m/z = 473 [M + Na]+, 923.0 [2 M + Na]+. Anal. Calcd (%) for C24H22N2O5S: C, 63.98; H, 4.92; N, 6.22. Found: C, 64.05; H, 5.17; N, 6.02.
Compound 5d (cis-isomer): white crystals, mp 147 °C. 1H NMR (200 MHz, CDCl3): δ = 0.93 (t, J = 8.0 Hz, 3 H), 2.18 (q, J = 7.2 Hz, 2 H), 2.20 (s, 3 H), 5.11 (s, 1 H), 6.60 (d, J = 8.0 Hz, 2 H), 6.78 (d, J = 8.0 Hz, 2 H), 6.85-6.89 (m, 2 H), 7.02-7.09 (m, 3 H), 7.87 (d, J = 9.0 Hz, 2 H), 8.18 (d, J = 9.0 Hz, 2 H). 13C NMR (50 MHz, CDCl3): δ = 9.31, 21.23, 32.76, 69.15, 69.98, 124.34, 127.27, 127.38, 128.17, 128.27, 128.87, 129.00, 130.54, 134.63, 138.87, 144.41, 150.76, 167.92. IR (KBr): ν = 1781 (C=O) cm-1. MS (ES+): m/z = 473 [M + Na]+, 923.0 [2 M + Na]+. Anal. Calcd (%) for C24H22N2O5S: C, 63.98; H, 4.92; N, 6.22. Found: C, 63.99; H, 5.02; N, 6.21.
Compound 5e (trans-isomer): white crystals, mp 116 °C. 1H NMR (200 MHz, CDCl3): δ = 0.64 (t, J = 7.6 Hz, 3 H), 1.50-1.68 (m, 1 H), 1.85-2.03 (m, 1 H), 5.53 (s, 1 H), 7.04-7.11 (m, 2 H), 7.24-7.37 (m, 6 H), 8.10 (d, J = 9.0 Hz, 2 H), 8.34 (d, J = 9.2 Hz, 4 H). 13C NMR (50 MHz, CDCl3): δ = 8.74, 27.65, 65.81, 68.34, 124.52, 126.24, 126.72, 127.53, 127.86, 128.24, 129.18, 129.21, 136.52, 137.08, 143.98, 168.17. IR (KBr): ν = 1782 (C=O) cm-1. MS (ES+): m/z = 465.0 [M + Na]+, 907.0 [2 M + Na]+, 332.1, 641.2, 774.0. Anal. Calcd (%) for C21H18N2O5S2: C, 57.00; H, 4.10; N, 6.33. Found: C, 56.99; H, 4.10; N, 6.30.
Compound 5e (cis-isomer): white crystals, mp 124 °C. 1H NMR (200 MHz, CDCl3): δ = 0.97 (t, J = 7.2 Hz, 3 H), 2.25 (q, J = 8.0 Hz, 2 H), 5.49 (s, 1 H), 6.73-6.75 (m, 2 H), 6.97-7.04 (m, 3 H), 7.11-7.18 (m, 3 H), 7.93 (d, J = 9.04 Hz, 2 H), 8.25 (d, J = 9.04 Hz, 2 H). 13C NMR (50 MHz, CDCl3): δ = 9.33, 32.35, 64.91, 70.50, 124.35, 126.40, 127.17, 127.92, 128.54, 128.90, 129.08, 134.51, 137.21, 144.38, 150.79, 167.23. IR (KBr): ν = 1790 (C=O) cm-1. MS (ES+): m/z = 465.0 [M + Na]+, 907.0 [2 M + Na]+, 332.1, 641.2, 774.0. Anal. Calcd (%) for C21H18N2O5S2: C, 57.00; H, 4.10; N, 6.33. Found: C, 57.13; H, 4.15; N, 6.26.
Compound 5f (trans-isomer): white crystals, mp 182 °C. 1H NMR (200 MHz, CDCl3): δ = 0.66 (t, J = 7.4 Hz, 3 H), 1.26-1.43 (m, 1 H), 1.58-1.78 (m, 1 H), 5.82 (s, 1 H), 7.05-7.10 (m, 2 H), 7.34-7.38 (m, 3 H), 7.43-7.63 (m, 5 H), 7.87-7.97 (m, 2 H), 8.27 (d, J = 9.0 Hz, 2 H), 8.46 (d, J = 9.0 Hz, 2 H). 13C NMR (50 MHz, CDCl3): δ = 8.93, 24.11, 68.46, 68.84, 122.90, 124.75, 125.08, 125.17, 126.47, 126.90, 128.55, 129.45, 129.50, 129.58, 129.67, 130.91, 133.89, 136.62, 143.99, 169.70. IR (KBr): ν = 1787 (C=O) cm-1. MS (ES+): m/z = 518.8 [(2 M + 3 Na)/2]+. Anal. Calcd (%) for C27H22N2O5S: C, 66.65; H, 4.56; N, 5.76. Found: C, 66.77; H, 4.78; N, 5.59.
Compound 5f (cis-isomer): white crystals, mp 186 °C. 1H NMR (200 MHz, CDCl3): δ = 0.97 (t, J = 7.6 Hz, 3 H), 2.26-2.47 (m, 2 H), 6.05 (s, 1 H), 6.69-6.99 (m, 6 H), 7.50-7.69 (m, 4 H), 7.83 (d, J = 7.8 Hz, 1 H), 8.02 (d, J = 8.2 Hz, 1 H), 8.15 (d, J = 9.0 Hz, 2 H), 8.38 (d, J = 9.0 Hz, 2 H). 13C NMR (50 MHz, CDCl3): δ = 9.47, 31.21, 64.86, 71.61, 121.70, 124.65, 125.05, 126.08, 126.80, 127.17, 127.58, 128.08, 128.96, 129.34, 129.49, 129.64, 131.32, 133.45, 134.12, 138.28, 144.41, 168.62. IR (KBr): ν = 1782 (C=O) cm-1. MS (ES+): m/z = 518.8 [(2 M + 3 Na)/2]+. Anal. Calcd (%) for C27H22N2O5S: C, 66.65; H, 4.56; N, 5.76. Found: C, 66.58; H, 4.87; N, 5.54.
Compound 5g (trans-isomer): light yellow crystals, mp 143 °C. 1H NMR (200 MHz, CDCl3): δ = 0.59 (t, J = 7.4 Hz, 3 H), 1.26-1.49 (m, 1 H), 1.69-1.87 (m, 1 H), 3.86 (s, 3 H), 3.92 (s, 3 H), 5.16 (s, 1 H), 6.84 (s, 1 H), 6.88-6.89 (m, 2 H), 7.18-7.39 (m, 5 H), 8.13 (d, J = 9.0 Hz, 2 H), 8.35 (d, J = 9.0 Hz, 2 H). 13C NMR (50 MHz, CDCl3): δ = 8.73, 27.05, 56.13, 56.19, 68.15, 69.92, 110.21, 111.25, 119.92, 124.58, 125.88, 126.18, 128.13, 129.22, 137.48, 143.91, 149.33, 149.81, 151.06, 168.80. IR (KBr): ν = 1793 (C=O) cm-1. MS (ES+): m/z = 518.8 [M + Na]+, 829.0. Anal. Calcd (%) for C25H24N2O7S: C, 60.47; H, 4.87; N, 5.64. Found: C, 60.41; H, 4.83; N, 5.63.
Compound 5g (cis-isomer): yellow crystals, mp 146 °C. 1H NMR (200 MHz, CDCl3): δ = 0.94 (t, J = 7.4 Hz, 3 H), 2.18 (q, J = 7.4 Hz, 2 H), 3.21 (s, 3 H), 3.79 (s, 3 H), 5.08 (s, 1 H), 5.82 (s, 1 H), 6.57-6.59 (m, 2 H), 6.84-6.92 (m, 2 H), 7.06-7.09 (m, 3 H), 7.93 (d, J = 9.0 Hz, 2 H), 8.26 (d, J = 9.0 Hz, 2 H). 13C NMR (50 MHz, CDCl3): δ = 9.33, 32.59, 55.43, 55.93, 69.16, 69.94, 110.29, 110.62, 121.84, 124.30, 125.72, 127.24, 127.50, 128.44, 128.99, 129.18, 134.91, 144.42, 148.52, 149.53, 150.78, 167.89. IR (KBr): ν = 1787 (C=O) cm-1. MS (ES+): m/z = 518.8 [M + Na]+, 829.0. Anal. Calcd (%) for C25H24N2O7S: C, 60.47; H, 4.87; N, 5.64. Found: C, 60.47; H, 4.90; N, 5.67.
Compound 7a (trans-isomer): white crystals, mp 163 °C. 1H NMR (200 MHz, CDCl3): δ = 1.18 (s, 3 H), 5.28 (s, 1 H), 7.20-7.42 (m, 10 H), 8.15 (d, J = 9.0 Hz, 2 H), 8.37 (d, J = 9.0 Hz, 2 H). 13C NMR (50 MHz, CDCl3): δ = 19.95, 64.13, 70.04, 124.61, 125.41, 126.99, 128.22, 128.98, 129.20, 129.25, 129.38, 133.58, 139.55, 143.98, 151.05, 169.08. IR (KBr): ν = 1787 (C=O) cm-1. MS (ES+):
m/z = 445.1 [M + Na]+, 867.0 [2 M + Na]+. Anal. Calcd (%) for C22H18N2O5S: C, 62.55; H, 4.29; N, 6.63. Found: C, 63.19; H, 4.64; N, 6.63.
Compound 7a (cis-isomer): white crystals, mp 142 °C. 1H NMR (200 MHz, CDCl3): δ = 1.81 (s, 3 H), 5.12 (s, 1 H), 6.71-6.77 (m, 2 H), 6.86-6.93 (m, 2 H), 6.95-7.16 (m, 6 H), 7.98 (d, J = 9.0 Hz, 2 H), 8.29 (d, J = 9.0 Hz, 2 H). 13C NMR (50 MHz, CDCl3): δ = 25.44, 65.97, 71.10, 124.49, 126.75, 127.57, 127.91, 128.26, 128.48, 128.95, 129.08, 133.62, 135.84, 144.15, 150.94, 168.47. IR (KBr): ν = 1791 (C=O) cm-1. MS (ES+): m/z = 445.1 [M + Na]+, 867.0 [2 M + Na]+. Anal. Calcd (%) for C22H18N2O5S: C, 62.55; H, 4.29; N, 6.63. Found: C, 63.14; H, 4.60; N, 6.50.
Compound 7b: Analytical data were consistent with those for 5a.
Compound 7c: white crystals, mp 156 °C. 1H NMR (200 MHz, CDCl3): δ = 5.86 (s, 1 H), 6.87-7.21 (m, 10 H), 7.28-7.48 (m, 5 H), 8.00 (d, J = 9.0 Hz, 2 H), 8.26 (d, J = 9.0 Hz, 2 H). 13C NMR (50 MHz, CDCl3): δ = 69.6, 73.30, 124.44, 126.91, 127.58, 127.80, 128.03, 128.30, 128.36, 129.03, 129.07, 129.22, 133.40, 135.58, 138.72, 143.87, 150.90, 166.71. IR (KBr): ν = 1781 (C=O) cm-1. MS (ES+):
m/z = 507.0 [M + Na]+. Anal. Calcd (%) for C27H20N2O5S: C, 66.93; H, 4.16; N, 5.78. Found: C, 66.97; H, 4.31; N, 5.77.
Compound 7d: white crystals, mp 168 °C. 1H NMR (200 MHz, CDCl3): δ = 1.06-1.38 (m, 4 H), 1.46-1.66 (m, 6 H), 1.72-2.02 (m, 2 H), 4.85 (s, 1 H), 7.11-7.33 (m, 5 H), 8.12 (d, J = 8.8 Hz, 2 H), 8.38 (d, J = 8.8 Hz, 2 H). 13C NMR (50 MHz, CDCl3): δ = 22.83, 23.71, 28.98, 29.08,29.98, 35.42, 64.28, 70.50, 124.60, 127.11, 128.79, 128.98, 129.15, 134.09, 144.19, 150.99, 171.32. IR (KBr) ν = 1787 (C=O) cm-1. MS (ES+): m/z = 437.2 [M + Na]+. Anal. Calcd (%) for C21H22N2O5S: C, 60.85; H, 5.35; N, 6.76. Found: C, 60.71; H, 5.47; N, 6.69.
27
Banik I.
Becker FF.
Banik BK.
J. Med. Chem.
2003,
46:
12
28
Li B.
Wang Y.
Du DM.
Xu J.
J. Org. Chem.
2007,
72:
990
29
Alcaide B.
Rodriguez-Vicente A.
Tetrahedron Lett.
1999,
40:
2005
30
Love BE.
Raje PS.
Wilams TC.
Synlett
1994,
493
31
Otomaru Y.
Tokunaga N.
Shintani R.
Hayashi T.
Org. Lett.
2005,
7:
307
32
Baigrie LM.
Seiklay HR.
Tidwell TT.
J. Am. Chem. Soc.
1985,
107:
5391
33
Kanizsai I.
Gyónfalvi S.
Szakonyi Z.
Sillanpää R.
Fülöp F.
Green Chem.
2007,
9:
357
34
The Chemistry of β-Lactams
Page MI.
Chapman and Hall;
London:
1992.